Oxygen Biotherapeutics Announces Plan to Regionalize Its Sales & Marketing Efforts for Its Dermacyte Oxygenating Skin Care Product Line
Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) today announced that the Company has modified its sales and marketing effort to focus on the regional U.S. markets of South Florida and North Carolina. Per the plan, promotional efforts will be highly targeted to support existing internal sales efforts, current client sales efforts, and to build brand awareness and grow market share for the Dermacyte brand. This effort is part of an overall program designed to capitalize on the relationships the company has built over the last year in the top markets that have adopted Dermacyte cosmetics into their practices.
In addition, the company plans to introduce new packaging of its flagship products, Dermacyte Concentrate and Dermacyte Oxygenating Eye Complex. The new packaging will incorporate feedback generated from customers regarding product volume, pricing and dispensing.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.